IQVIA Holdings Inc - Asset Resilience Ratio

Latest as of December 2025: 7.15%

IQVIA Holdings Inc (IQV) has an Asset Resilience Ratio of 7.15% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read IQV current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$2.14 Billion

Cash + Short-term Investments

Total Assets

$29.94 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how IQVIA Holdings Inc's Asset Resilience Ratio has changed over time. See IQV book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down IQVIA Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see IQV market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$1.98 Billion	6.61%
Short-term Investments	$161.00 Million	0.54%
Total Liquid Assets	$2.14 Billion	7.15%

Asset Resilience Insights

Limited Liquidity: IQVIA Holdings Inc maintains only 7.15% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

IQVIA Holdings Inc Industry Peers by Asset Resilience Ratio

Compare IQVIA Holdings Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Revvity Inc. NYSE:RVTY	Diagnostics & Research	0.00%
Clinica Baviera MC:CBAV	Diagnostics & Research	14.23%
SMO ClinPlus Co. Ltd. SHE:301257	Diagnostics & Research	14.36%
RHYTHM Biosciences Ltd AU:RHY	Diagnostics & Research	2.74%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Check-Cap Ltd F:7CC	Diagnostics & Research	70.29%
Avricore Health Inc V:AVCR	Diagnostics & Research	0.75%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%

Annual Asset Resilience Ratio for IQVIA Holdings Inc (2011–2025)

The table below shows the annual Asset Resilience Ratio data for IQVIA Holdings Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	7.15%	$2.14 Billion	$29.94 Billion	+0.30pp
2024-12-31	6.85%	$1.84 Billion	$26.90 Billion	+1.24pp
2023-12-31	5.61%	$1.50 Billion	$26.68 Billion	+0.44pp
2022-12-31	5.17%	$1.31 Billion	$25.34 Billion	-0.82pp
2021-12-31	5.98%	$1.48 Billion	$24.69 Billion	-1.76pp
2020-12-31	7.74%	$1.90 Billion	$24.56 Billion	+3.88pp
2019-12-31	3.87%	$899.00 Million	$23.25 Billion	-0.29pp
2018-12-31	4.16%	$938.00 Million	$22.55 Billion	-0.26pp
2017-12-31	4.42%	$1.00 Billion	$22.74 Billion	-1.42pp
2016-12-31	5.84%	$1.24 Billion	$21.21 Billion	+6.68pp
2015-12-31	-0.84%	$-32.91 Million	$3.93 Billion	+0.21pp
2014-12-31	-1.04%	$-34.50 Million	$3.31 Billion	+0.27pp
2013-12-31	-1.32%	$-40.35 Million	$3.07 Billion	+0.12pp
2012-12-31	-1.44%	$-35.95 Million	$2.50 Billion	-0.49pp
2011-12-31	-0.95%	$-22.11 Million	$2.32 Billion	--

pp = percentage points

About IQVIA Holdings Inc

NYSE:IQV USA Diagnostics & Research

Market Cap

$29.92 Billion

Market Cap Rank

#923 Global

#391 in USA

Share Price

$176.42

Change (1 day)

+9.62%

52-Week Range

$137.00 - $244.29

All Time High

$282.61